Dr. Rollins served from 2004 to 2020 as Dana-Farber’s first Chief Scientific Officer. During his tenure, he helped establish the Lurie Family Imaging Facility in South Boston and the PROFILE project, one of the first efforts that obtained clinically relevant genetic information on every patient seen at a single cancer center. He went on to spearhead a consortium that combines similar data from eighteen centers around the world and makes the information available to all scientists. In his own research, Dr. Rollins’s lab elucidated mechanisms that control white blood cell movement throughout the body. He also identified the genetic abnormalities underlying Langerhans Cell Histiocytosis, a rare childhood neoplasm. His observations now form the basis of effective new therapies.

Dr. Rollins graduated from Amherst College and received his MD and PhD degrees from Case Western Reserve University. He has been a member of the faculty at Dana-Farber and Harvard Medical School since 1989 where he holds the Linde Family Professorship. He is a member of the American Society for Clinical Investigation, a member of the Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Amherst College awarded him an honorary Doctor of Science.